Geode Capital Management, LLC Cns Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$0.26 - $1.05 $5,656 - $22,841
21,754 Added 20.28%
129,016 $43,000
Q3 2021

Nov 12, 2021
BUY
$1.4 - $1.98 $9,892 - $13,990
7,066 Added 7.05%
107,262 $159,000
Q2 2021

Aug 13, 2021
BUY
$1.71 - $2.42 $67,394 - $95,377
39,412 Added 64.84%
100,196 $196,000
Q1 2021

May 12, 2021
BUY
$1.72 - $4.18 $104,548 - $254,077
60,784 New
60,784 $145,000

Others Institutions Holding CNSP

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About CNS Pharmaceuticals, Inc.

CNSP Quotes by TradingView
  • Ticker CNSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,032,500
  • Market Cap $4.4M
  • Description
  • CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....
More about CNSP
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email